+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
AB Science - logo

AB Science is a pharmaceutical company specializing in the discovery, development, and commercialization of novel targeted therapies named protein kinase inhibitors. Their therapies treat diseases such as cancers, inflammatory diseases, and central nervous system diseases in both human and veterinary medicine. It serves hospitals and specialist physicians. The company was founded in 2001 and is headquartered in Paris, France.

Neurodegenerative Disorder Therapeutics Global Market Report 2024 - Product Thumbnail Image

Neurodegenerative Disorder Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Asthma - Pipeline Review, H2 2020 - Product Thumbnail Image

Asthma - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 811 Pages
  • Global
From
Colorectal Cancer - Pipeline Review, H1 2020 - Product Thumbnail Image

Colorectal Cancer - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 3889 Pages
  • Global
From
Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 1814 Pages
  • Global
From
Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Insight, 2024 - Product Thumbnail Image

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Multiple sclerosis - Pipeline Insight, 2024 - Product Thumbnail Image

Multiple sclerosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 100 Pages
  • Global
From
Lou Gehrig's disease - Pipeline Insight, 2024 - Product Thumbnail Image

Lou Gehrig's disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Gastric Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Gastric Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 550 Pages
  • Global
From
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1560 Pages
  • Global
From
Alzheimer's Disease: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Alzheimer's Disease: Global Drug Forecast and Market Analysis to 2028

  • Report
  • May 2020
  • 218 Pages
  • Global
From
Head and Neck Cancer Therapeutics Global Market Report 2024 - Product Thumbnail Image

Head and Neck Cancer Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Gestational Trophoblastic Disease Global Market Report 2024 - Product Thumbnail Image

Gestational Trophoblastic Disease Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Amyotrophic Lateral Sclerosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • January 2023
  • 142 Pages
  • Global
From
Amyotrophic Lateral Sclerosis Market - Forecast (2022 - 2027) - Product Thumbnail Image

Amyotrophic Lateral Sclerosis Market - Forecast (2022 - 2027)

  • Report
  • March 2022
  • 132 Pages
  • Global
From
B-Cell Chronic Lymphocytic Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

B-Cell Chronic Lymphocytic Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 139 Pages
  • Global
From
Global Head and Neck Cancer Therapeutics Market, By Type (Diagnostic Methods v/s Treatment Type), By Treatment Type (By Disease Indication, By Route of Administration, By Therapeutic Class), By End User, By Region, Company, Opportunities and Forecast, 2027 - Product Thumbnail Image

Global Head and Neck Cancer Therapeutics Market, By Type (Diagnostic Methods v/s Treatment Type), By Treatment Type (By Disease Indication, By Route of Administration, By Therapeutic Class), By End User, By Region, Company, Opportunities and Forecast, 2027

  • Report
  • April 2022
  • 358 Pages
  • Global
From
Global Amyotrophic Lateral Sclerosis Treatment Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Thumbnail Image

Global Amyotrophic Lateral Sclerosis Treatment Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • February 2024
  • 188 Pages
  • Global
From
Primary Progressive Multiple Sclerosis - Pipeline Insight, 2024 - Product Thumbnail Image

Primary Progressive Multiple Sclerosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • May 2020
  • 304 Pages
  • Global
From
Systemic Mastocytosis - Pipeline Insight, 2024 - Product Thumbnail Image

Systemic Mastocytosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Loading Indicator